-
1
-
-
85036447765
-
Effect of antidepressant therapy on health care utilization and costs in primary care
-
1995 Jun 9; Chicago (IL). Indianapolis (IN): Eli Lilly and Company
-
Croghan TW, Lair TJ, Engelhart L, et al. Effect of antidepressant therapy on health care utilization and costs in primary care [working paper]. Association for Health Services Research Meeting; 1995 Jun 9; Chicago (IL). Indianapolis (IN): Eli Lilly and Company, 1996
-
(1996)
Association for Health Services Research Meeting
-
-
Croghan, T.W.1
Lair, T.J.2
Engelhart, L.3
-
3
-
-
0017347943
-
Foundations of cost-effectiveness analysis for health and medical practices
-
Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 296: 716-21
-
(1977)
N Engl J Med
, vol.296
, pp. 716-721
-
-
Weinstein, M.C.1
Stason, W.B.2
-
4
-
-
0022589229
-
Policy state areas and properties of benefit-cost/utility analysis
-
Anderson JP, Bush JW, Chen M, et al. Policy state areas and properties of benefit-cost/utility analysis. JAMA 1986; 255: 794-5
-
(1986)
JAMA
, vol.255
, pp. 794-795
-
-
Anderson, J.P.1
Bush, J.W.2
Chen, M.3
-
5
-
-
0024989695
-
The CE plane: A graphic representation of cost-effectiveness
-
Black WC. The CE plane: a graphic representation of cost-effectiveness. Med Decis Making 1990; 10: 212-4
-
(1990)
Med Decis Making
, vol.10
, pp. 212-214
-
-
Black, W.C.1
-
6
-
-
8244251436
-
In search of power and significance: Issues in the design and analysis of stochastic cost-effectiveness studies in health care
-
O'Brien BJ, Drummond MF, Labelle RJ, et al. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care. Med Care 1994; 30: 231-43
-
(1994)
Med Care
, vol.30
, pp. 231-243
-
-
O'Brien, B.J.1
Drummond, M.F.2
Labelle, R.J.3
-
8
-
-
0029129619
-
Use of confidence intervals and sample size calculations in health economic studies
-
Sacristan JA, Day SJ, Navarro O, et al. Use of confidence intervals and sample size calculations in health economic studies. Ann Pharmacother 1995; 29: 719-25
-
(1995)
Ann Pharmacother
, vol.29
, pp. 719-725
-
-
Sacristan, J.A.1
Day, S.J.2
Navarro, O.3
-
9
-
-
0030011253
-
Estimating confidence intervals for cost-effectiveness ratios: An example from a randomized trial
-
Chaudhary MA, Stearns SC. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Stat Med 1996; 15: 1447-58
-
(1996)
Stat Med
, vol.15
, pp. 1447-1458
-
-
Chaudhary, M.A.1
Stearns, S.C.2
-
10
-
-
84945737762
-
A leisurely look at the bootstrap, jackknife and cross-validation
-
Efron B, Gong G. A leisurely look at the bootstrap, jackknife and cross-validation. Am Statistician 1983; 37: 36-48
-
(1983)
Am Statistician
, vol.37
, pp. 36-48
-
-
Efron, B.1
Gong, G.2
-
13
-
-
0003514372
-
-
[Chapter 17: Procedure MULTTEST, 371-405]. Cary (NC): SAS Institute, Inc.
-
SAS Institute, Inc. Technical report P-229, SAS/STAT Software: changes and enhancements, release 6.07 [Chapter 17: Procedure MULTTEST, 371-405]. Cary (NC): SAS Institute, Inc., 1992
-
(1992)
Technical Report P-229, SAS/STAT Software: Changes and Enhancements, Release 6.07
-
-
-
15
-
-
0026681390
-
Pattern of recurrence of illness of an episode of major depression
-
Maj M, Veltro F, Pirozzi R, et al. Pattern of recurrence of illness of an episode of major depression. Am J Psychiatry 1992; 149: 795-800
-
(1992)
Am J Psychiatry
, vol.149
, pp. 795-800
-
-
Maj, M.1
Veltro, F.2
Pirozzi, R.3
-
16
-
-
0027462773
-
Practice guideline for major depressive disorder in adults
-
AHCPR Guidelines. Practice guideline for major depressive disorder in adults. Am J Psychiatry 1993; 150 (2 Suppl.): 1-26
-
(1993)
Am J Psychiatry
, vol.150
, Issue.2 SUPPL.
, pp. 1-26
-
-
-
17
-
-
0028809136
-
How can care for depression become more cost-effective?
-
Sturm R, Wells KB. How can care for depression become more cost-effective? JAMA 1995; 273: 51-8
-
(1995)
JAMA
, vol.273
, pp. 51-58
-
-
Sturm, R.1
Wells, K.B.2
-
18
-
-
0026806719
-
Treatments of depression and the functional capacity to work
-
Mintz J, Mintz LI, Arruda MJ, et al. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992; 49: 761-8
-
(1992)
Arch Gen Psychiatry
, vol.49
, pp. 761-768
-
-
Mintz, J.1
Mintz, L.I.2
Arruda, M.J.3
-
20
-
-
0000125534
-
Sample selection as a specification error
-
Heckman J. Sample selection as a specification error. Econometrica 1979; 47 (1): 153-61
-
(1979)
Econometrica
, vol.47
, Issue.1
, pp. 153-161
-
-
Heckman, J.1
-
24
-
-
0028846528
-
Direct cost of depression: Analysis of treatment costs of paroxeline versus imipramine in Canada
-
LaPierre Y, Bentkover J, Schaimbaum S, et al. Direct cost of depression: Analysis of treatment costs of paroxeline versus imipramine in Canada. Can J Psychiatry 1995; 40: 370-7
-
(1995)
Can J Psychiatry
, vol.40
, pp. 370-377
-
-
LaPierre, Y.1
Bentkover, J.2
Schaimbaum, S.3
-
25
-
-
0028789056
-
Modeling the cost effectiveness of antidepressant treatment in primary care
-
Revicki DA, Brown RE, Palmer W, et al. Modeling the cost effectiveness of antidepressant treatment in primary care. Pharmacoeconomics 1995; 8: 524-40
-
(1995)
Pharmacoeconomics
, vol.8
, pp. 524-540
-
-
Revicki, D.A.1
Brown, R.E.2
Palmer, W.3
-
26
-
-
0028246430
-
The cost of treatment dropout in depression: A cost-benefit analysis of fluoxetine vs. tricyclics
-
LePen C, Levy E, Ravily V, et al. The cost of treatment dropout in depression: a cost-benefit analysis of fluoxetine vs. tricyclics. J Affect Disord 1994; 31: 1-18
-
(1994)
J Affect Disord
, vol.31
, pp. 1-18
-
-
Lepen, C.1
Levy, E.2
Ravily, V.3
-
27
-
-
0028956012
-
A model to evaluate the cost effectiveness of oral therapies in the management of patients with major depressive disorders
-
Einarson TR, Arikian S, Sweeney S, et al. A model to evaluate the cost effectiveness of oral therapies in the management of patients with major depressive disorders. Clin Ther 1995; 17: 136-53
-
(1995)
Clin Ther
, vol.17
, pp. 136-153
-
-
Einarson, T.R.1
Arikian, S.2
Sweeney, S.3
-
28
-
-
0003224270
-
The financial implications of starting treatment with a selective serotonin reuptake inhibitor or tricyclic antidepressant in drug-naive depressed patients
-
Jonsson B, Rosenbaum J, editors. London: John Wiley & Son Ltd.
-
Boyer WF, Feighnew JP. The financial implications of starting treatment with a selective serotonin reuptake inhibitor or tricyclic antidepressant in drug-naive depressed patients. In: Jonsson B, Rosenbaum J, editors. Health economics of depression. London: John Wiley & Son Ltd., 1993: 65-75
-
(1993)
Health Economics of Depression
, pp. 65-75
-
-
Boyer, W.F.1
Feighnew, J.P.2
-
29
-
-
0028224810
-
What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment
-
Jonsson B, Bebbington PE. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry 1994; 164: 665-73
-
(1994)
Br J Psychiatry
, vol.164
, pp. 665-673
-
-
Jonsson, B.1
Bebbington, P.E.2
-
30
-
-
0028149112
-
Antidepressant pharmacotherapy: Economic outcomes in a health maintenance organization
-
Sclar DA, Robison LM, Skaer TL, et al. Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization. Clin Ther 1994; 16: 715-30
-
(1994)
Clin Ther
, vol.16
, pp. 715-730
-
-
Sclar, D.A.1
Robison, L.M.2
Skaer, T.L.3
-
31
-
-
0029040591
-
Economic valuation of amitriptyline, desipramine, nortriptyline, and sertraline in the management of patients with depression
-
Skaer TL, Sclar DA, Robison LM, et al. Economic valuation of amitriptyline, desipramine, nortriptyline, and sertraline in the management of patients with depression. Curr Ther Res 1995; 56: 556-67
-
(1995)
Curr Ther Res
, vol.56
, pp. 556-567
-
-
Skaer, T.L.1
Sclar, D.A.2
Robison, L.M.3
-
32
-
-
0029922652
-
Initial antidepressant choice: Effectiveness and cost of fluoxetine vs tricyclic antidepressants
-
Simon GE, VonKorff M, Heiligenstein JH, et al. Initial antidepressant choice: effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 1996; 275: 1897-902
-
(1996)
JAMA
, vol.275
, pp. 1897-1902
-
-
Simon, G.E.1
Vonkorff, M.2
Heiligenstein, J.H.3
-
33
-
-
8244221026
-
Limit theorem, central
-
Johnson NL, Kotz J, Read CB, editors. New York: John Wiley and Sons
-
Heyde CC. Limit theorem, central. In: Johnson NL, Kotz J, Read CB, editors. Encyclopedia of statistical sciences. Vol 4, New York: John Wiley and Sons, 1982: 651-5
-
(1982)
Encyclopedia of Statistical Sciences
, vol.4
, pp. 651-655
-
-
Heyde, C.C.1
|